214450 — PharmaResearch Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩1tn
- KR₩1tn
- KR₩261bn
- 91
- 26
- 62
- 67
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 14,851 | 32,452 | 46,824 | 43,434 | 77,265 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 5,988 | 5,681 | 7,017 | 25,099 | 15,815 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -8,623 | -13,905 | 2,207 | -26,593 | -40,660 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 19,272 | 32,392 | 65,449 | 52,542 | 64,945 |
Capital Expenditures | -9,784 | -35,383 | -23,788 | -17,758 | -13,197 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -1,853 | -826 | -69,966 | 5,850 | -31,471 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -11,637 | -36,209 | -93,755 | -11,908 | -44,668 |
Financing Cash Flow Items | -175 | -21.9 | -90.3 | — | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -9,104 | 11,088 | 42,965 | -9,301 | -25,969 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1,358 | 6,977 | 14,959 | 31,257 | -5,687 |